Verastem (VSTM) Other Non Operating Income (2019 - 2026)
Verastem (VSTM) posted quarterly Other Non Operating Income of -$61000.0 for Q1 2026, down 52.5% year-over-year from -$128421.1 in Q1 2025, and down 64.86% quarter-over-quarter from -$37000.0 in Q3 2025.
Powered by 
Analysis
Verastem (VSTM) Other Non Operating Income (2019 - 2026) Analysis & Trends
Verastem's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$61000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 52.5% year-over-year to -$61000.0; the TTM figure through Mar 2026 stood at -$208000.0 (down 56.39% YoY), while the FY2025 annual figure was -$1.8 million, down 1384.55% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$61000.0, down from -$37000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $28000.0 in Q1 2022, with the low at -$110000.0 in Q2 2025.
- The 5-year median for Other Non Operating Income is -$27000.0 (2024), against an average of -$27062.5.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income tumbled 766.67% in 2023, then soared 116.33% in 2024.
- Verastem's Other Non Operating Income stood at -$7000.0 in 2022, then plunged by 600.0% to -$49000.0 in 2023, then jumped by 116.33% to $8000.0 in 2024, then tumbled by 562.5% to -$37000.0 in 2025, then plunged by 64.86% to -$61000.0 in 2026.
- Business Quant data shows VSTM's Other Non Operating Income at -$61000.0 in Q1 2026, -$37000.0 in Q3 2025, and -$110000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Verastem | 800.93 Mn | 664.58 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -40,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2020 | -1.58 Mn |
| Mar 31, 2020 | -1.31 Mn |